These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31679885)

  • 1. Fifty years of research on antithrombotic therapy: Achievements and disappointments.
    Hirsh J; Eikelboom JW; Chan NC
    Eur J Intern Med; 2019 Dec; 70():1-7. PubMed ID: 31679885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined antithrombotic therapy of potential value in acute atrial fibrillation related stroke.
    Kelley RE
    Eur J Neurol; 2015 Jul; 22(7):1027-8. PubMed ID: 25382709
    [No Abstract]   [Full Text] [Related]  

  • 3. Current development in antithrombotic therapy.
    Mammen EF
    Semin Thromb Hemost; 2004 Dec; 30(6):605-7. PubMed ID: 15630665
    [No Abstract]   [Full Text] [Related]  

  • 4. Association of improved outcome in acute ischaemic stroke patients with atrial fibrillation who receive early antithrombotic therapy: analysis from VISTA.
    Abdul-Rahim AH; Fulton RL; Frank B; Tatlisumak T; Paciaroni M; Caso V; Diener HC; Lees KR;
    Eur J Neurol; 2015 Jul; 22(7):1048-55. PubMed ID: 25319957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Historical Hallmarks of Anticoagulation and Antiplatelet Agents.
    Tsoucalas G; Chevallier J; Karamanou M; Papaioannou T; Sgantzos M; Androutsos G
    Curr Pharm Des; 2016; 22(13):1857-61. PubMed ID: 26750139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A historical review of hemostasis, thrombosis, and antithrombotic therapy.
    Stassen JM; Nyström A
    Ann Plast Surg; 1997 Sep; 39(3):317-29. PubMed ID: 9326716
    [No Abstract]   [Full Text] [Related]  

  • 7. Antithrombotic drugs.
    Treat Guidel Med Lett; 2011 Oct; 9(110):61-6; quiz 2 p following 66. PubMed ID: 21941228
    [No Abstract]   [Full Text] [Related]  

  • 8. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
    Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
    Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
    Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
    J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
    Lopes RD; Rao M; Simon DN; Thomas L; Ansell J; Fonarow GC; Gersh BJ; Go AS; Hylek EM; Kowey P; Piccini JP; Singer DE; Chang P; Peterson ED; Mahaffey KW
    Am J Med; 2016 Jun; 129(6):592-599.e1. PubMed ID: 26797080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Future directions in antithrombotic therapy: emphasis on venous thromboembolism.
    Axelrod DA; Wakefield TW
    J Am Coll Surg; 2001 May; 192(5):641-51. PubMed ID: 11333101
    [No Abstract]   [Full Text] [Related]  

  • 12. Initial Stroke Severity in Patients With Atrial Fibrillation According to Antithrombotic Therapy Before Ischemic Stroke.
    Jung YH; Kim YD; Kim J; Han SW; Oh MS; Lee JS; Lee KY
    Stroke; 2020 Sep; 51(9):2733-2741. PubMed ID: 32811392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual (Anticoagulant Plus Single Antiplatelet) vs Triple (Anticoagulant Plus Dual Antiplatelet) Antithrombotic Therapy - "Real World" Experience.
    Effron MB; Gibson CM
    Prog Cardiovasc Dis; 2018; 60(4-5):531-536. PubMed ID: 29360524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative management of antithrombotic therapy: a case-based narrative review.
    Chen AT; Patel M; Douketis JD
    Intern Emerg Med; 2022 Jan; 17(1):25-35. PubMed ID: 34652572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
    Dzeshka MS; Lip GY
    Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ; Goodman SG; Bhatt DL; Eikelboom JW; Price MJ; Moliterno DJ; Cannon CP; Tanguay JF; Granger CB; Mauri L; Holmes DR; Gibson CM; Faxon DP
    Circulation; 2018 Jul; 138(5):527-536. PubMed ID: 30571525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.
    Chackalamannil S
    J Med Chem; 2006 Sep; 49(18):5389-403. PubMed ID: 16942011
    [No Abstract]   [Full Text] [Related]  

  • 18. Major Bleeding Rates in Atrial Fibrillation Patients on Single, Dual, or Triple Antithrombotic Therapy.
    van Rein N; Heide-Jørgensen U; Lijfering WM; Dekkers OM; Sørensen HT; Cannegieter SC
    Circulation; 2019 Feb; 139(6):775-786. PubMed ID: 30586754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood clots: the good, the bad, and the deadly. Those arising from atherosclerosis and atrial fibrillation can be very dangerous.
    Harv Heart Lett; 2012 Apr; 22(8):4-5. PubMed ID: 22872883
    [No Abstract]   [Full Text] [Related]  

  • 20. Temporal trends in prevalence and antithrombotic treatment among Asians with atrial fibrillation undergoing percutaneous coronary intervention: A nationwide Korean population-based study.
    Park J; Choi EK; Han KD; Choi YJ; Lee E; Choe W; Lee SR; Cha MJ; Lim WH; Kang J; Park KW; Oh S; Lip GYH
    PLoS One; 2019; 14(1):e0209593. PubMed ID: 30645601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.